Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - william degrado

1 Results Sort By:
Small molecule inhibitors of Integrin α2β1
Problem: There is a need for new therapeutics that prevent cardiovascular diseases with minimal effects on normal blood clotting. Integrin α2β1 is a good therapeutic target since it can lead to cardiovascular diseases including stroke or myocardial infarction when overexpressed, but does not severely impair normal bleeding when under-expressed....
Published: 11/28/2018   |   Inventor(s): William DeGrado, Joel Bennett
Keywords(s):  
Category(s): Therapeutics & Vaccines